F628-1717 Screening compound: 4-(5-CYCLOPENTYL-1,2,4-OXADIAZOL-3-YL)-N-[2-OXO-2-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO)ETHYL]BENZAMIDE

F628-1717 Screening compound: 4-(5-CYCLOPENTYL-1,2,4-OXADIAZOL-3-YL)-N-[2-OXO-2-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO)ETHYL]BENZAMIDE
F628-1717 Screening compound: 4-(5-CYCLOPENTYL-1,2,4-OXADIAZOL-3-YL)-N-[2-OXO-2-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO)ETHYL]BENZAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F628-1717
4-(5-CYCLOPENTYL-1,2,4-OXADIAZOL-3-YL)-N-[2-OXO-2-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO)ETHYL]BENZAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F628-1717

Molecular Formula

C26H28N4O3 (C26 H28 N4 O3)

Compound Name

4-(5-CYCLOPENTYL-1,2,4-OXADIAZOL-3-YL)-N-[2-OXO-2-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO)ETHYL]BENZAMIDE

IUPAC name

n/a

SMILES

O=C(CNC(c(cc1)ccc1-c1noc(C2CCCC2)n1)=O)NC(CCC1)c2c1cccc2

InChI

InChI=1S/C26H28N4O3/c31-23(28-22-11-5-9-17-6-3-4-10-21(17)22)16-27-25(32)19-14-12-18(13-15-19)24-29-26(33-30-24)20-7-1-2-8-20/h3-4,6,10,12-15,20,22H,1-2,5,7-9,11,16H2,(H,27,32)(H,28,31)/t22-/m0/s1

InChI Key

ABSKIDKWAOSIPL-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27180053

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.674

Distribution Coefficient, logD

5.674

Water Solubility, LogSw

-5.91

Polar Surface Area

80.931

Acid Dissociation Constant (pKa)

12.55

Base Dissociation Constant (pKb)

-1.03

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.50

F628-1717 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F628-1717 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F628-1717?
Check Price and Availability of F628-1717, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F628-1717 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F628-1717
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F628-1717
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F628-1717 available by request